May 7, 2018—Federal appeals court judges in Washington focused largely on procedural issues during a May 4 hearing over a nearly 30 percent cut in Medicare drug payments to certain 340B hospitals. A lawsuit by hospital groups and health systems over the cut was the subject of oral arguments before a three-judge panel of the U.S. Court of Appeals for the District of Columbia … [Read more...]
Appeals Court Expedites Lawsuit to Stop Deep Medicare Cuts to 340B Hospitals
January 31, 2018—A federal appeals court has agreed to fast-track its consideration of a lawsuit aimed at stopping a nearly 30 percent cut in 340B disproportionate share hospitals’ (DSH) and rural referral centers’ (RRC) Medicare Part B drug reimbursement that took effect on Jan. 1. … [Read more...]
Judge Lets CMS Impose Medicare Part B Cuts on 340B Hospitals Starting Jan. 1
December 30, 2017—U.S. District Judge Rudolph Contreras yesterday dismissed on procedural grounds the lawsuit to block a 28.5 percent reduction in 340B hospitals’ Medicare Part B drug reimbursement. The case was dismissed on the basis that hospitals have not yet presented a specific claim for reimbursement that has received the reduced payment rate. The decision left open the … [Read more...]
Senator, Patient Advocate Support 340B in Hearing
December 13, 2017—Members of the Senate Health, Education, Labor, and Pensions (HELP) Committee heard a powerful defense of the 340B drug discount program yesterday at a hearing on the new National Academies of Sciences (NAS) report on why medicines cost so much and what can be done about it. The committee’s senior Democratic member, Sen. Patty Murray (D-Wash.), noted that … [Read more...]
CMS Finalizes Nearly 30 Percent Cut in Medicare Part B Drug Payments to 340B Hospitals
November 1, 2017—The Centers for Medicare & Medicaid Services late today published a final Outpatient Prospective Payment System (OPPS) regulation that cuts Medicare Part B drug reimbursement to hospitals in the 340B drug discount program for separately payable drugs by nearly 30 percent, from average sales price (ASP) plus 6 percent to ASP minus 22.5 percent. The reduction … [Read more...]
Senators to HHS: Start Enforcing 340B Manufacturer Penalties Rule
October 31, 2017—Thirteen U.S. Senators have asked the Department of Health and Human Services to stop delaying enforcement of a 340B drug discount program final rule to police drug manufacturer overcharging. “HHS has conducted several rounds of public comment and had more than seven years to consider” the 340B ceiling price and manufacturer civil monetary penalties final … [Read more...]
340B Health Urges HHS to Start Enforcing Regulation to Police Drug Industry Overcharging
September 20, 2017— The U.S. Department of Health and Human Services should not delay a long-overdue federal regulation to punish drug manufacturers that illegally overcharge safety-net hospitals and other healthcare providers for lifesaving medicines, thousands of safety-net providers enrolled in the federal 340B drug discount program said in written comments to HHS … [Read more...]